Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...
FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
| DelveInsight The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such as Debio 4126 (Debiopharm International SA), ALXN2420 ...
A major new study from Denmark offers reassuring news for women considering hormone therapy to manage menopause symptoms. Researchers found that menopausal hormone therapy—often called hormone ...
Objectives To investigate the potential long-term impacts of adult growth hormone deficiency (GHD). Design Observational, retrospective matched cohort. Setting UK Clinical Practice Research Datalink ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results